Drug Profiles

Minocycline antibiotics are used to treat acne, rosacea, and perioral dermatitis. Considerations like appropriate dosing, cost of treatments, and patient compliance issues are discussed as well as efficacy.

Penlac (Ciclopirox), and its pharmacokinetics, delivery system, safety, and patient selection are discussed. Monotherapy and combination therapy and its patient criteria are discussed.

An in depth second part to the side-effects, safety and risks associated with Eumovate (Clobetasone Butyrate). Allergies, local, and systemic side-effects are discussed.

Various potential side-effects and risks of Diane-35 are discussed. Monitoring advice for physicians and follow-up exams to check on progress are advised.

Accutane® (Isotretinoin) Side Effects, Safety and Risks are discussed. A comprehensive review of the drug, side-effects, and other considerations.

An in-depth review of Clindoxyl® Gel (Clindamycin Phosphate and Benzoyl Peroxide) including clinical experience, mechanism of action, indications, dosing, efficacy, as well as compliance issues and side-effects.

Accutane was approved for severe, recalcitrant nodular cystic acne unresponsive to other first line therapies. Off label use is also covered.

Elidel (Pimecrolimus) is indicated for patients with mild to moderate atopic dermatitis. This article discusses patient profiles, and use in a variety of dermatological conditions.

Side effects, safety and risks of Minocycline (Minocin, Dynacin, Vectrin) are discussed in this article. Topics include drug interactions, bacterial resistance, as well as other adverse effects.

A thorough look at Dovobet® (Calcipotriol and Betamethasone Dipropionate) including pharmacokinetics, mechanism of action, indications, dosing, efficacy, as well as compliance issues and side-effects.

Imiquimod was first indicated and used for external genital and perianal warts/ condyloma acuminata. Other HPV warts have also been treated by this drug, often in combination with more conventional therapy including cryotherapy and CO2 laser therapy, in immunocompetent and immunosuppressed patients.

Efficacy of short and long-term Accutane® (Isotretinoin) treatment is discussed. Info on relapse, re-treatment and expert opinion is provided as well.

Dosing, efficacy, compliance and cost of Diane-35, as well as pharmacokinetics are discussed. Various side-effects are covered as well.

Bactroban (Mupirocin) and its potential side effects, safety profile, and risks are discussed. Precautions to be considered are also detailed.

Bactroban (Mupirocin) is discussed in detail including mechanism of action, clinical experience, and indication, such as for burns, and various infections.

Accutane (Isotretinoin) was approved for the treatment of acne. While in recent years it has been shrouded by some controversy, it remains an essential tool in the treatment of severe or persistent acne. Few drugs provide an actual cure for acne and Isotretinoin is such a medication.

Imiquimod drug profile including Actinic Keratosis, Bowen’s disease, Squamous cell carcinoma and Genital Warts.

Eumovate (Clobetasone Butyrate), patient profiles, dosing, efficacy, and compliance issues are discussed as well as a comparison in vehicles between cream and ointment.

Bactroban (Mupirocin) efficacy and prophylactic use for nasal carriage and patients who are S. Aureus carriers are discussed. Bacterial resistance issues are also covered.

Amevive® (Alefacept) and its clinical experience, and clinical evidence are discussed. As a biologic, safety profiles, and mechanisms of action are also covered.

What is the cost of Accutane treatment? See the comparison of different topical treatments with Accutane® (Isotretinoin), with the corresponding cost of treatment.

Proper patient counselling of the risks versus benefits of Accutane® (Isotretinoin) treatment is very important to ensure compliance with therapy.

Diane-35 (Cyproterone Acetate and Ethinyl Estradiol), its indications, and clinical experience are discussed. Patient profiles, suitable and unsuitable candidates are also discussed.

Amevive (Alefacept), clinical experience, patient profiles, indications, dosing and cost are discussed in this article.

Dermatological and non-dermatological indications for minocycline ((Minocin®, Dynacin®, Vectrin®) are discussed in depth in this article.

Dosing, efficacy, compliance and cost of Aldara (Imiquimod) are discussed in the context of genital wart treatment.

Imiquimod side effects with reference to Erythema, Edema, Induration, Vesiculation, Excoriation, Scaling and flaking.

Elidel (Pimecrolimus) is discussed in the context of dosing, efficacy, compliance, and cost of treatment are discussed.

Soriatane (Acitretin)Treatment: Efficacy, compliance and cost are covered. Use in psoriasis both as monotherapy and combination therapy are included.

Dosing, compliance, side-effects, and the cost of Cutivate (Fluticasone Propionate) are discussed in this article.

Elidel (Pimecrolimus), its side effects, safety, and risks are discussed in this article. Various potential risks are discussed and debated.

This article summarizes the clinical indications and findings of Cutivate (Fluticasone Propionate). Guidelines are also provided for treating atopic dermatitis.

Elidel® (Pimecrolimus) and physician's clinical experience in treating atopic dermatitis are observed and discussed in this article.

Learn about who would be a suitable candidate for Accutane® (Isotretinoin) treatment and who should avoid it.

Soriatane (Acitretin) Treatment: Side effects, safety, and risks are covered. Skin, liver, lipids, bone/muscle, ocular, and other effects and their manifestations are discussed.

Bactroban (Mupirocin) Patient Profiles - suitable and unsuitable patients, dosing, compliance and cost issues, as well as cost comparisons with other treatments are detailed in this article.

Suitable and unsuitable patient profiles for minocycline is discussed in this article. Important takeaways from clinical experience with minocycline is also in this article.

Indications for using Soriatane (Acitretin) are discussed. Psoriasis, and various off label uses such as for darier's disease, lamellar ichthyosis, erythrokeratoderma variabilis, lichen planus, and pityriasis rubra pilaris is included.

Acitretin (Soriatane®) is approved in the US and Canada to treat severe psoriasis, but is only approved in Canada to treat other disorders of keratinization.

Soriatane (Acitretin) patient, profile and dosing, suitable and unsuitable candidate patients are discussed. This is for use in psoriasis patients.